Literature DB >> 33326792

The Proinflammatory Cytokine IL-36γ Is a Global Discriminator of Harmless Microbes and Invasive Pathogens within Epithelial Tissues.

Thomas Macleod1, Joseph S Ainscough1, Christina Hesse2, Sebastian Konzok2, Armin Braun2, Anna-Lena Buhl3, Joerg Wenzel3, Paul Bowyer4, Yutaka Terao5, Sarah Herrick6, Miriam Wittmann7, Martin Stacey8.   

Abstract

Epithelial tissues represent vital interfaces between organisms and their environment. As they are constantly exposed to harmful pathogens, innocuous commensals, and environmental microbes, it is essential they sense and elicit appropriate responses toward these different types of microbes. Here, we demonstrate that the epithelial cytokine interleukin-36γ (IL-36γ) acts as a global discriminator of pathogenic and harmless microbes via cell damage and proteolytic activation. We show that intracellular pro-IL-36γ is upregulated by both fungal and bacterial epithelial microbes; yet, it is only liberated from cells, and subsequently processed to its mature, potent, proinflammatory form, by pathogen-mediated cell damage and pathogen-derived proteases. This work demonstrates that IL-36γ senses pathogen-induced cell damage and proteolytic activity and is a key initiator of immune responses and pathological inflammation within epithelial tissues. As an apically located epithelial proinflammatory cytokine, we therefore propose that IL-36γ is critical as the initial discriminator of harmless microbes and invasive pathogens within epithelial tissues. Crown
Copyright © 2020. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL-36; alarmins; cytokines; epithelial immunity; interleukin-36; pathogen discrimination; proteases; psoriasis; streptococcus; virulence factors

Mesh:

Substances:

Year:  2020        PMID: 33326792      PMCID: PMC7758160          DOI: 10.1016/j.celrep.2020.108515

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  9 in total

1.  Treponema denticola Induces Interleukin-36γ Expression in Human Oral Gingival Keratinocytes via the Parallel Activation of NF-κB and Mitogen-Activated Protein Kinase Pathways.

Authors:  Annie N Hinson; Colin G Hawkes; Christopher S Blake; Zackary R Fitzsimonds; Bin Zhu; Gregory Buck; Richard J Lamont; Daniel P Miller
Journal:  Infect Immun       Date:  2022-08-30       Impact factor: 3.609

2.  The mechanism on Prevotella melaninogenica promoting the inflammatory progression of oral lichen planus.

Authors:  Pan Xu; Ru-Ru Shao; Shi Zhang; Zheng-Wu Tan; Yi-Ting Guo; Yuan He
Journal:  Clin Exp Immunol       Date:  2022-08-19       Impact factor: 5.732

Review 3.  The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier.

Authors:  Tom Macleod; Anna Berekmeri; Charlie Bridgewood; Martin Stacey; Dennis McGonagle; Miriam Wittmann
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

Review 4.  Interleukin-36 Cytokines in Infectious and Non-Infectious Lung Diseases.

Authors:  Hernán F Peñaloza; Rick van der Geest; Joel A Ybe; Theodore J Standiford; Janet S Lee
Journal:  Front Immunol       Date:  2021-11-23       Impact factor: 7.561

5.  Increased Levels of Interleukin-36 in Obesity and Type 2 Diabetes Fuel Adipose Tissue Inflammation by Inducing Its Own Expression and Release by Adipocytes and Macrophages.

Authors:  Gema Frühbeck; Javier Gómez-Ambrosi; Beatriz Ramírez; Amaia Mentxaka; Amaia Rodríguez; Sara Becerril; Gabriel Reina; Victor Valentí; Rafael Moncada; Camilo Silva; Victoria Catalán
Journal:  Front Immunol       Date:  2022-02-09       Impact factor: 7.561

6.  IL-1α and IL-36 Family Cytokines Can Undergo Processing and Activation by Diverse Allergen-Associated Proteases.

Authors:  Valentina Frezza; Zaneta Najda; Pavel Davidovich; Graeme P Sullivan; Seamus J Martin
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 7.  IL-36 Cytokines: Their Roles in Asthma and Potential as a Therapeutic.

Authors:  Hongna Dong; Yuqiu Hao; Wei Li; Wei Yang; Peng Gao
Journal:  Front Immunol       Date:  2022-07-12       Impact factor: 8.786

Review 8.  The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?

Authors:  Xiaofang Wang; Panpan Yi; Yuejin Liang
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

Review 9.  IL-36 cytokines in inflammatory and malignant diseases: not the new kid on the block anymore.

Authors:  James Byrne; Kevin Baker; Aileen Houston; Elizabeth Brint
Journal:  Cell Mol Life Sci       Date:  2021-08-07       Impact factor: 9.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.